ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00287235
Recruitment Status : Completed
First Posted : February 6, 2006
Last Update Posted : April 5, 2017
Sponsor:
Collaborator:
Gambro Renal Products, Inc.
Information provided by (Responsible Party):
Baxter Healthcare Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2003
  Actual Study Completion Date : April 2004